Drug Type Small molecule drug |
Synonyms 1-(p-tert-Butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine, Buclizine hydrochloride (USAN), NSC-25141 + [4] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (08 Apr 1957), |
Regulation- |
Molecular FormulaC28H34Cl2N2 |
InChIKeyBFUBEWDYLSDZEV-UHFFFAOYSA-N |
CAS Registry129-74-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02089 | Buclizine Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Dizziness | United States | 08 Apr 1957 | |
| Motion Sickness | United States | 08 Apr 1957 | |
| Nausea | United States | 08 Apr 1957 | |
| Vertigo | United States | 08 Apr 1957 | |
| Vomiting | United States | 08 Apr 1957 |





